APRIL COURSEY: Open Payments
NPI 1154788941 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,995 in 47 payments from 11 companies in 2025. Trend: 2023 $604 · 2024 $1,695 · 2025 $1,995
Food & beverage: $1,911Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $727 |
| Janssen Scientific Affairs, LLC | 3 | $310 |
| Janssen Biotech, Inc. | 3 | $299 |
| Madrigal Pharmaceuticals | 4 | $292 |
| GENZYME CORPORATION | 1 | $122 |
| Ardelyx, Inc. | 1 | $106 |
| Novo Nordisk Inc | 1 | $46 |
| Boston Scientific Corporation | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
Products named: TREMFYA, REZDIFFRA, CREON, LINZESS, SKYRIZI, DUPIXENT, IBSRELA, XIFAXAN.
Industry payments across TX — which companies pay providers there.
